Fig. 6From: Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents3D structure of VEGFR-2 (pdb id: 4agd) receptorBack to article page